Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Nateglinide · 2 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| Nateglinide | EXPERIMENTAL | Nateglinide Tablets 120 mg of Dr. Reddys Laboratories Limited |
| Starlix | ACTIVE_COMPARATOR | Starlix Tablets 120 mg of Novartis |
| Name | Type | Description |
|---|---|---|
| Nateglinide | DRUG | Nateglinide Tablets 120 mg |
Inclusion Criteria: * Male or female, smoker or non-smoker, 18 years of age and older. * Capable of consent Exclusion Criteria: Subjects to whom any of the following applies will be excluded from the study: * Clinically significant illnesses within 4 weeks prior to the administration of the stud...